Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse modelRadiosensitivierung durch Histon-Deacetylasehemmung im Osteosarkom- Mausmodell

被引:0
作者
C. Blattmann
M. Thiemann
A. Stenzinger
A. Christmann
E. Roth
V. Ehemann
J. Debus
A.E. Kulozik
W. Weichert
P.E. Huber
S. Oertel
A. Abdollahi
机构
[1] Olgahospital,Pädiatrie 5
[2] University Children’s Hospital of Heidelberg,Department of Pediatric Oncology, Hematology and Immunology
[3] Institute of Radiation Oncology (HIRO),Departments of Radiotherapy, Molecular
[4] National Center for Tumor diseases (NCT), and Translational Radiation Oncology
[5] German Cancer Research Center (DKFZ) ,Institute of Pathology
[6] University of Heidelberg,Center of Cancer Systems Biology
[7] St. Elizabeth’s Medical Center,undefined
[8] Tufts University School of Medicine,undefined
来源
Strahlentherapie und Onkologie | 2013年 / 189卷
关键词
Osteosarcoma; Radiotherapy; Histone deacetylase inhibition; Suberoylanilide hydroxamic acid; CD95; Osteosarkom; Radiotherapie; Histon-Deacetylasehemmung; Suberoylanilide Hydroxamic Acid (SAHA); CD95;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:957 / 966
页数:9
相关论文
共 41 条
[1]  
Belka S(1998)Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters Radiat Res 149 588-3968
[2]  
Bellarosa M(2012)undefined Int J Oncol41 1486-undefined
[3]  
Bielack I(2009)undefined Cancer Treat Res 152 289-undefined
[4]  
Bielack undefined(2008)undefined Curr Treat Options Oncol 9 67-undefined
[5]  
Bielack undefined(2002)undefined J Clin Oncol 20 776-undefined
[6]  
Blattmann undefined(2010)undefined Int J Radiat Oncol Biol Phys 78 237-undefined
[7]  
Blattmann undefined(2012)undefined Strahlenther Onkol 188 168-undefined
[8]  
Bots undefined(2009)undefined Clin Cancer Res 15 3970-undefined
[9]  
Bridges undefined(2011)undefined Clin Cancer Res 17 5638-undefined
[10]  
Dickinson undefined(2012)undefined Invest New Drugs 28 S3-undefined